Andres Y. Maldonado
Stock Analyst at H.C. Wainwright
(4.91)
# 245
Out of 4,988 analysts
334
Total ratings
52.1%
Success rate
34.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Y. Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRBP Corbus Pharmaceuticals Holdings | Reiterated: Buy | $35 | $7.48 | +367.91% | 20 | Sep 15, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $65 → $70 | $46.65 | +50.05% | 33 | Sep 15, 2026 | |
| VSTM Verastem | Reiterated: Buy | $18 | $7.44 | +141.94% | 10 | Sep 14, 2026 | |
| IMNM Immunome | Reiterated: Buy | $40 | $23.97 | +66.88% | 8 | Sep 11, 2026 | |
| ENGN enGene Therapeutics | Reiterated: Buy | $4 | $1.91 | +109.42% | 15 | Sep 9, 2026 | |
| TCRX TScan Therapeutics | Downgraded: Hold | $7 → $1 | $0.3119 | +220.62% | 12 | Sep 9, 2026 | |
| IMRX Immuneering | Reiterated: Buy | $14 | $4.48 | +212.50% | 2 | Aug 27, 2026 | |
| NBP NovaBridge Biosciences | Reiterated: Buy | $9 | $1.60 | +462.50% | 13 | Aug 20, 2026 | |
| CADL Candel Therapeutics | Reiterated: Buy | $23 | $10.85 | +111.98% | 14 | Aug 14, 2026 | |
| MNPR Monopar Therapeutics | Reiterated: Buy | $125 | $96.47 | +29.57% | 12 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $15.34 | +225.95% | 12 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $18 | $6.44 | +179.50% | 9 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $22 | $14.77 | +48.95% | 21 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $3.55 | +660.56% | 17 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $4.12 | +191.26% | 3 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $74.62 | +34.01% | 27 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $4.14 | +214.01% | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $3.11 | +221.54% | 13 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $38 | $17.62 | +115.66% | 12 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $8.48 | +76.89% | 26 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $11.19 | +78.73% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $4 | $0.965 | +314.51% | 27 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $4.89 | n/a | 11 | Nov 11, 2024 |
Corbus Pharmaceuticals Holdings
Sep 15, 2026
Reiterated: Buy
Price Target: $35
Current: $7.48
Upside: +367.91%
Scholar Rock Holding
Sep 15, 2026
Reiterated: Buy
Price Target: $65 → $70
Current: $46.65
Upside: +50.05%
Verastem
Sep 14, 2026
Reiterated: Buy
Price Target: $18
Current: $7.44
Upside: +141.94%
Immunome
Sep 11, 2026
Reiterated: Buy
Price Target: $40
Current: $23.97
Upside: +66.88%
enGene Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $4
Current: $1.91
Upside: +109.42%
TScan Therapeutics
Sep 9, 2026
Downgraded: Hold
Price Target: $7 → $1
Current: $0.3119
Upside: +220.62%
Immuneering
Aug 27, 2026
Reiterated: Buy
Price Target: $14
Current: $4.48
Upside: +212.50%
NovaBridge Biosciences
Aug 20, 2026
Reiterated: Buy
Price Target: $9
Current: $1.60
Upside: +462.50%
Candel Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $23
Current: $10.85
Upside: +111.98%
Monopar Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $125
Current: $96.47
Upside: +29.57%
Aug 13, 2026
Reiterated: Buy
Price Target: $50
Current: $15.34
Upside: +225.95%
Aug 12, 2026
Reiterated: Buy
Price Target: $24 → $18
Current: $6.44
Upside: +179.50%
Aug 12, 2026
Reiterated: Buy
Price Target: $20 → $22
Current: $14.77
Upside: +48.95%
Aug 12, 2026
Reiterated: Buy
Price Target: $27
Current: $3.55
Upside: +660.56%
Aug 10, 2026
Reiterated: Buy
Price Target: $12
Current: $4.12
Upside: +191.26%
Aug 7, 2026
Reiterated: Buy
Price Target: $100
Current: $74.62
Upside: +34.01%
Aug 7, 2026
Reiterated: Buy
Price Target: $13
Current: $4.14
Upside: +214.01%
Aug 7, 2026
Reiterated: Buy
Price Target: $10
Current: $3.11
Upside: +221.54%
Aug 5, 2026
Reiterated: Buy
Price Target: $40 → $38
Current: $17.62
Upside: +115.66%
Aug 4, 2026
Reiterated: Buy
Price Target: $15
Current: $8.48
Upside: +76.89%
Aug 4, 2026
Reiterated: Buy
Price Target: $20
Current: $11.19
Upside: +78.73%
Dec 19, 2025
Reiterated: Buy
Price Target: $10 → $4
Current: $0.965
Upside: +314.51%
Nov 11, 2024
Reiterated: Buy
Price Target: $4
Current: $4.89
Upside: n/a